<p>N-[[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-sulfonyl]propanamide and pharmaceutically acceptable salts thereof are useful prodrugs of the selective COX-2 inhibitory drug celecoxib, which can be administrated to a subject by any suitable route.</p>
申请公布号
WO2004043934(A1)
申请公布日期
2004.05.27
申请号
WO2003US35222
申请日期
2003.11.03
申请人
PHARMACIA CORPORATION;GRANETO, MATTHEW, J.;EWING, GARY, D.
